Ariel Dora Stern

Harvard Business School

Associate Professor

Morgan Hall 433

Harvard Business School

Boston, MA MASSACHUSETTS 02163

United States

http://www.hbs.edu/astern

SCHOLARLY PAPERS

6

DOWNLOADS

528

SSRN CITATIONS
Rank 31,771

SSRN RANKINGS

Top 31,771

in Total Papers Citations

9

CROSSREF CITATIONS

11

Scholarly Papers (6)

1.

The Impact of the Entry of Biosimilars: Evidence from Europe

Morton, Fiona M. Scott, Ariel Dora Stern, and Scott Stern. "The impact of the entry of biosimilars: evidence from Europe." Review of Industrial Organization 53, no. 1 (2018): 173-210.
Number of pages: 71 Posted: 24 Jul 2016 Last Revised: 04 May 2019
Fiona M. Scott Morton, Ariel Dora Stern and Scott Stern
Yale School of Management, Harvard Business School and Massachusetts Institute of Technology (MIT) - Sloan School of Management
Downloads 309 (100,056)
Citation 6

Abstract:

Loading...

Biosimilars; Biologics; Pharmaceutical Competition; Health Care Spending; Innovation

2.

Recalls, Innovation, and Competitor Response: Evidence from Medical Device Firms

Harvard Business School Working Paper 19-028 , Georgetown McDonough School of Business Research Paper No. 3251630
Number of pages: 49 Posted: 12 Oct 2018 Last Revised: 31 Mar 2019
George Ball, Jeffrey Thomas Macher and Ariel Dora Stern
Operations and Decision Technologies Dept, Kelley School of Business, Indiana University, Georgetown University - McDonough School of Business - Strategy, Economics and Policy and Harvard Business School
Downloads 70 (337,089)
Citation 3

Abstract:

Loading...

3.

Physician Beliefs and Patient Preferences: A New Look at Regional Variation in Health Care Spending

NBER Working Paper No. w19320
Number of pages: 64 Posted: 17 Aug 2013 Last Revised: 17 Apr 2019
Harvard University - Department of Economics, Dartmouth College - Department of Economics, Harvard Business School and Geisel School of Medicine at Dartmouth
Downloads 56 (377,648)
Citation 3

Abstract:

Loading...

4.

Innovation Under Regulatory Uncertainty: Evidence from Medical Technology

Stern, A.D., Innovation under Regulatory Uncertainty: Evidence from Medical Technology, Journal of Public Economics. Final version published online: 06-Dec-2016. DOI information: 10.1016/j.jpubeco.2016.11.010, Journal of Public Economics, Vol. 145, 2017
Number of pages: 20 Posted: 17 Oct 2016 Last Revised: 13 Aug 2018
Ariel Dora Stern
Harvard Business School
Downloads 43 (422,688)
Citation 5

Abstract:

Loading...

Regulation, Innovation, FDA, Medical Devices

5.

Pioneer (Dis-)advantages in Markets for Technology

Harvard Business School Working Paper No. 19-043
Number of pages: 39 Posted: 01 May 2019 Last Revised: 10 Nov 2019
Moritz Fischer, Joachim Henkel and Ariel Dora Stern
Technische Universität München (TUM), TUM School of Management - Technische Universität München (TUM) and Harvard Business School
Downloads 35 (455,326)

Abstract:

Loading...

First-Mover Advantages, Markets for Technology, M&A, Technology Acquisition, Medical Devices

6.

Characterizing the Drug Development Pipeline for Precision Medicines

NBER Working Paper No. w24026
Number of pages: 70 Posted: 20 Nov 2017
Amitabh Chandra, Craig L. Garthwaite and Ariel Dora Stern
Harvard University - Harvard Kennedy School (HKS), Northwestern University - Department of Management & Strategy and Harvard Business School
Downloads 15 (564,193)
  • Add to Cart

Abstract:

Loading...